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Summary
 
Lipopolysaccharide (LPS) fluorescently labeled with boron dipyrromethane (BODIPY) first
binds to the plasma membrane of CD14-expressing cells and is subsequently internalized. Intra-
cellular LPS appears in small vesicles near the cell surface and later in larger, punctate structures
identified as the Golgi apparatus. To determine if membrane (m)CD14 directs the movement
of LPS to the Golgi apparatus, an mCD14 chimera containing enhanced green fluorescent pro-
tein (mCD14–EGFP) was used to follow trafficking of mCD14 and BODIPY–LPS in stable
transfectants. The chimera was expressed strongly on the cell surface and also in a Golgi com-
plex–like structure. mCD14–EGFP was functional in mediating binding of and responses to
LPS. BODIPY–LPS presented to the transfectants as complexes with soluble CD14 first colo-
calized with mCD14–EGFP on the cell surface. However, within 5–10 min, the BODIPY–
LPS distributed to intracellular vesicles that did not contain mCD14–EGFP, indicating that
mCD14 did not accompany LPS during endocytic movement. These results suggest that mo-
nomeric LPS is transferred out of mCD14 at the plasma membrane and traffics within the cell
independently of mCD14. In contrast, aggregates of LPS were internalized in association with
mCD14, suggesting that LPS clearance occurs via a pathway distinct from that which leads to
signaling via monomeric LPS.
Key words: enhanced green fluorescent protein • U373 cells • intracellular trafﬁcking
 
C
 
ells that express plasma membrane–bound (m)CD14,
 
1
 
either naturally or through transfection, bind bacterial
LPS. Monomeric LPS is removed from LPS aggregates and
reaches mCD14 by a two-step process in serum (1). The
serum protein LPS binding protein (LBP) binds to LPS ag-
gregates and transfers monomers to a soluble (s) form of
CD14, also present in serum. sCD14, in turn, may transfer
LPS either to serum lipoprotein particles, causing LPS neu-
tralization, or to cells, leading to production of cytokines
and other responses. Transfer of LPS between CD14 mole-
cules is a rapid process (2), suggesting that the movement of
LPS from sCD14 to mCD14 on mCD14-bearing cells is
likely to be more rapid than the movement of LPS from
sCD14 to the surfaces of cells that do not express CD14.
The importance of mCD14 to the binding of LPS and
the cellular responses that follow is underscored by a vari-
ety of observations. Blockade of LPS binding to mCD14
on leukocytes with mAbs (3) abrogates responses such as
cytokine production by monocytes (4) and enhanced inte-
grin-dependent adhesion by neutrophils (2, 5). In addition,
paroxysmal nocturnal hemoglobinuria, a disease character-
ized by a variable deficiency in the expression of mCD14
and other glycosylphosphatidyl inositol (GPI)-linked pro-
teins on hemopoietic cells, renders monocytes less sensitive
to LPS (6–8). Perhaps the strongest evidence for the pri-
macy of mCD14 in mediating responses to LPS is the ob-
servation that monocytes from CD14-deficient mice show
a strongly attenuated cytokine response to LPS (9). More-
over, transfection with mCD14 endows various cell types
that do not otherwise express CD14 with the ability either
to become responsive to LPS (10) or to become sensitive to
much lower concentrations of LPS (11, 12). Thus, mCD14
serves as the initial site of interaction between LPS and the
surfaces of CD14-bearing cells.
Several lines of evidence suggest that after binding to
mCD14, LPS must be internalized to initiate intracellular
 
A preliminary version of this work was presented at the Fifth Conference of
 
the International Endotoxin Society, Santa Fe, NM, September 12–15, 1998.
 
1
 
Abbreviations used in this paper:
 
 BODIPY, boron dipyrromethane; DAF,
decay accelerating factor; EGFP, enhanced green fluorescent protein;
FBS, fetal bovine serum; GPI, glycosylphosphatidyl inositol; LBP, LPS
binding protein; m, membrane-bound; PI-PLC, phosphatidyl inositol
phospholipase C; s, soluble; SP, signal peptide; TLR, Toll-like receptor. 
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signaling leading to cellular responses. Recently, we and
others have observed that fluorescently labeled LPS is rap-
idly endocytosed when it is presented to neutrophils or cul-
tured human monocytes as monomeric LPS complexed
with sCD14 (13, 14). In neutrophils, integrin-mediated ad-
hesion in response to LPS exhibits a lag of 10–20 min and
is completely blocked by phosphatidyl inositol 3 kinase in-
hibitors or by lowering the temperature to 19
 
8
 
C, two treat-
ments that prevent vesicular transport (13). Thieblemont
and Wright demonstrated that macrophages from mice
with the LPS-hyporesponsive (
 
Lps
 
d
 
) trait are defective in
vesicular transport of LPS (14). Furthermore, LPS antago-
nists block both the transport of LPS inside the cell (15)
and cellular responses to LPS. Internalization of LPS may
therefore be a key process for eliciting responses from cells
expressing mCD14.
Although LPS internalization has been directly observed
under a variety of circumstances, the precise role of
mCD14 in this process is not known. The ability of CD14
to transfer LPS to high density lipoprotein particles (16)
and phospholipid micelles (17) suggests that mCD14 might
participate in the catalytic transfer of LPS to the lipid bi-
layer of the plasma membrane. LPS may then move within
the cell independently of mCD14 or in a vesicle also con-
taining mCD14. Alternatively, LPS may remain bound to
mCD14 while being internalized, exhibiting the behavior
of a classic ligand–receptor complex.
To determine whether mCD14 traffics along with LPS
from the plasma membrane to intracellular compartments,
we constructed a GPI-anchored fusion protein of CD14
and enhanced green fluorescent protein (EGFP) and used it
to follow the location of mCD14 in the astrocytoma cell
line U373. The fusion protein was expressed on the cell
surface in a fully functional form. Expression of mCD14–
EGFP endowed U373 cells with the ability to internalize
detectable amounts of fluorescently labeled LPS (BO-
DIPY–LPS). Using confocal microscopy, we observed that
BODIPY–LPS presented in a monomeric form colocalized
with mCD14 at the cell surface but distributed to intracel-
lular locations without mCD14 as soon as internalization of
LPS could be detected. Our observations suggest that mo-
nomeric LPS is rapidly transferred out of mCD14 at the
plasma membrane and traffics within the cell independently
of mCD14. Additional studies indicate that LPS aggregates
are trafficked differently from monomers. LPS aggregates
are known to be slowly internalized and directed to lyso-
somes (18), and we find that mCD14 remains associated
with LPS aggregates during internalization.
 
Materials and Methods
 
Construction of the mCD14–EGFP and mEGFP Chimeras.
 
pEGFP-N1 (Clontech) encodes EGFP, a bright red–shifted vari-
ant of GFP containing the amino acid substitutions phenylaline-
64
 
®
 
leucine and serine-65
 
®
 
threonine of GFPmut1 (19). An
 
mCD14–EGFP
 
 gene fusion was constructed in pEGFP-N1 in
two steps. First, a 1.2-kb BamHI fragment coding for the entire
 
CD14 protein minus the last eight COOH-terminal residues was
inserted into BamHI-digested pEGFP-N1, yielding pCD14–
EGFP. Second, a 116-bp BsrGI–NotI fragment, encoding the 36
COOH-terminal residues of decay accelerating factor (DAF) and
a stop codon, was inserted into BsrGI- plus NotI-digested
pCD14–EGFP, yielding pCD14–EGFP–GPI. The amino acid
sequence of the fusion protein coded by this construct is shown
(see Fig. 1 A).
Similarly, an 
 
mEGFP
 
 gene fusion was constructed by first
inserting a 116-bp BsrGI–NotI fragment, encoding the 36
COOH-terminal residues of DAF and a stop codon, into BsrGI-
plus NotI-digested pEGFP-N1, yielding pEGFP–GPI. Then, a
134-bp SalI–BamHI fragment coding for the first 19 NH
 
2
 
-termi-
nal residues, the signal peptide (SP) of CD14, was inserted into
SalI- plus BamHI-digested pEGFP–GPI, yielding pSP–EGFP–
GPI. The sequence of the fusion protein coded by this construct
is shown (see Fig. 1 B). These constructs placed the mCD14–
EGFP and mEGFP chimeras under the control of the cytomega-
lovirus promoter/enhancer and permitted the selection of stable
clones using geneticin.
The 1.2-kb BamHI fragment encoding most of CD14 was
synthesized by PCR using pcDNAI-neo-CD14 as a template
(20) and the primers 5
 
9
 
-GAG ATG GAT CCA CCA TGG AGC
GCG CGT CCT GC-3
 
9
 
 and 5
 
9
 
-GAG ATG GAT CCA GCA
CCA GGG TTC CCG A-3
 
9
 
. The 116-bp BsrGI–NotI fragment
encoding part of DAF was synthesized by RT-PCR using total
RNA from human monocytes as a template and the primers 5
 
9
 
-
AAT ATG TAC AAT AAA GGA AGT GGA ACC AC-3
 
9
 
 and
5
 
9
 
-TAA AGC GGC CGC TAA GTC AGC AAG CCC AT-3
 
9
 
.
The 134-bp SalI–BamHI fragment was synthesized by RT-PCR
using total RNA from human neutrophils as a template and the
primers 5
 
9
 
-ACG CGT CGA CGC CGC TGT GTA GGA
AAG-3
 
9 
 
and 5
 
9
 
-CGC GGA TCC GCA GAG ACG TGC ACC
AAT-3
 
9
 
. All syntheses were followed by digestion with the ap-
propriate restriction enzymes and gel purification. Both RT-
PCR amplifications were performed using the Gene Amp RNA
PCR kit purchased from Perkin-Elmer Corp. The PCR inser-
tions were sequenced to confirm the absence of PCR synthesis
errors.
 
U373 Cell Lines.
 
U373 cells were grown as monolayers in
RPMI (BioWhittaker, Inc.) supplemented with 10% heat-inacti-
vated fetal bovine serum (FBS; BioWhittaker, Inc.), penicillin/
streptomycin (100 U/ml and 100 
 
m
 
g/ml, respectively), and 2 mM
glutamine. For making stable transfectants, 10
 
5
 
 cells from a con-
fluent culture of U373 cells were seeded on a 35-mm cell culture
dish and grown to subconfluence for 24–48 h before transfection
with either pCD14–EGFP–GPI or pSP–EGFP–GPI. For each
dish, 1–2 
 
m
 
g of highly purified expression plasmid was used for
transfection with 6 
 
m
 
l lipofectamine (GIBCO BRL) according to
the manufacturer’s instructions. The DNA–lipofectamine mix-
ture remained on the cells for 6 h at 37
 
8
 
C and was then replaced
by RPMI with 10% FBS and 2 mM glutamine without antibiot-
ics. 72 h after transfection, the cells were trypsinized, plated at
clonal density, and selected with 0.5 mg/ml geneticin (GIBCO
BRL). After 3 wk, surviving cell colonies were visually screened
for fluorescence. Several positive clones were identified, isolated
using cloning rings, and expanded into cell lines for further anal-
ysis. U373–CD14 cells were obtained by selecting clones of
U373 cells stably transfected with pcDNAI-neo-CD14 as de-
scribed elsewhere (20).
 
sCD14 and LPS.
 
Recombinant human sCD14 was purified
from conditioned medium of Schneider-2 insect cells transfected
with cDNA encoding human CD14 as previously described (21). 
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LPS from 
 
Salmonella minnesota
 
 R595 was purchased from List Bi-
ological Labs. The fluoroprobe BODIPY 558/568 (Molecular
Probes, Inc.) was conjugated to unlabeled LPS micelles as previ-
ously described (22).
LPS–sCD14 and BODIPY–LPS–sCD14 complexes were
formed by incubating LPS or BODIPY–LPS (20 
 
m
 
g/ml), respec-
tively, with sCD14 (500 
 
m
 
g/ml) overnight at 37
 
8
 
C in Dulbecco’s
PBS (BioWhittaker, Inc.) with 0.5% pyrogen-free human serum
albumin (Centeon, Armour, and Berring Pharmaceutical Co.).
Previous work has shown that under these conditions all of the
LPS forms stoichiometric complexes with monomeric sCD14
and that these complexes efficiently stimulate cells and deliver
LPS to the plasma membrane (2, 3).
BODIPY–LPS aggregates were prepared by incubating BO-
DIPY–LPS at 1 
 
m
 
g/ml in FBS for 10 min at 37
 
8
 
C. The aggrega-
tion state of LPS was verified by monitoring its fluorescence
emission at 568 nm before and after the addition of detergent, as
described elsewhere (22). Adding 2% SDS to the BODIPY–LPS
aggregates led to a 10-fold increase in fluorescence due to the loss
of self-quenching as monomers were released from the aggre-
gates. In addition, aggregates observed directly by fluorescence
microscopy exhibited a pointillistic pattern of fluorescence, rather
than the very diffuse fluorescence seen with BODIPY–LPS–
sCD14 complexes.
 
Confocal Microscopy.
 
U373 transfectants were cultured for
24–48 h before experiments in RPMI without phenol red (Bio-
Whittaker, Inc.) supplemented with 10% FBS, antibiotics, and 2
mM glutamine on glass chamber slides (Nunc, Inc.) precoated
with 0.5% gelatin (Sigma Chemical Co.). The cells were washed
twice in HAP buffer (Dulbecco’s PBS, 0.05% human serum albu-
min, and 3 mM 
 
d
 
-glucose, containing 0.5 U/ml of aprotinin)
and incubated in HAP at 37
 
8
 
C with or without LPS–sCD14,
BODIPY–LPS–sCD14, or BODIPY–LPS aggregates. Slides
were washed twice with HAP and further incubated at 37
 
8
 
C. At
the end of the incubation, the plastic chamber and silicone gasket
were removed, and the slide was mounted in HAP for immediate
microscopic observation. For removal of cell surface mCD14–
EGFP with phosphatidyl inositol phospholipase C (PI-PLC), cells
on slides were incubated for 1 h in 20 mM Hepes, pH 7.4, and
150 mM NaCl on ice with 5 U/ml of PI-PLC (Boehringer
Mannheim).
When anti-CD14 mAb 26ic or 60b (23) was used, cells were
incubated with the antibody at 10 
 
m
 
g/ml in HAP buffer at 4
 
8
 
C for
30 min and washed twice with ice-cold HAP and once with HAP
at 37
 
8
 
C just before adding the BODIPY–LPS–sCD14 complexes.
Confocal scanning laser microscopy was performed using a
Nikon Optiphot-2 microscope with a 
 
3
 
60 objective (NA 1.4)
and Bio-Rad MRC 1024 instrumentation with a krypton/argon
laser. Unless otherwise noted, each image represents a single Kal-
man averaged (6–10 scans) optical section collected with a 2–3-
mm-diameter iris aperture. Optical sections were collected digi-
tally and analyzed using LaserSharp software (Bio-Rad Labs.). For
two-color images, each color was acquired sequentially. This was
necessary because EGFP has a broad peak of fluorescence, and
some signal bleedthrough was observed in the BODIPY–LPS
channel when simultaneous collection was attempted.
 
Intracellular Fluorescence.
 
Quenching of cell surface fluores-
cence by trypan blue was employed to both quantitate and
observe the distribution of intracellular mCD14–EGFP and
mEGFP. U373 transfectants were grown to confluence in a 96-
well culture plate and, after the experiment, the total fluorescence
associated with the cells was measured using a Cytofluor 4000
(PE Biosystems) (excitation 485 nm, emission 530 nm). Trypan
blue (200 
 
m
 
g/ml, ambient temperature) was added to the wells to
quench fluorescence from cell surface EGFP, and the remaining
fluorescence from intracellular mCD14–EGFP or mEGFP was
immediately measured. Intracellular fluorescence is expressed as a
percent of total fluorescence from triplicate samples. Trypan blue
was also used to quench cell surface EGFP on U373 transfectants
before observing the cells by confocal microscopy. After the ex-
perimental manipulation, U373 transfectants cultured on glass
chamber slides were washed once and mounted in HAP contain-
ing 200 
 
m
 
g/ml trypan blue before immediate observation.
 
IL-6 Production by U373 Cells.
 
U373 transfectants grown in
96-well cell culture plates were washed extensively with AIM-V
serum–free medium (GIBCO BRL) and incubated as indicated
in AIM-V medium containing 0.5 mg/ml human serum albu-
min. After 16 h at 37
 
8
 
C, the overlying medium was collected
from each well and assayed for IL-6 by ELISA as described (24).
 
SDS-PAGE and Western Blotting.
 
For each condition, 10
 
6
 
cells were lysed by incubation on ice for 20 min in 300 
 
m
 
l of 100
mM Tris/HCl, pH 8.0, 100 mM NaCl, 2 mM EDTA, 1% Tri-
ton X-100, 0.1% SDS, 0.3 U/ml aprotinin, 2 mM PMSF, 3 mM
diisopropyl fluorophosphate, 50 
 
m
 
g/ml benzamidine, and 5 
 
m
 
g/ml
each of antipain, leupeptin, chymostatin, and pepstatin A. Lysates
were centrifuged for 15 min at 12,000 
 
g
 
, and the supernatants
were prepared for SDS-PAGE under reducing conditions. SDS-
PAGE was run on a 4–20% gradient Tris–glycine gel (Novex).
Proteins were electrotransferred to nitrocellulose membranes and
detected with either an anti-EGFP rabbit pAb (Clontech) or an
anti-CD14 pAb (25). Horseradish peroxidase–conjugated goat
anti–rabbit IgG was used as the secondary antibody, and the en-
zymatic reaction was detected with an ECL kit (Amersham
Corp.). Purified rEGFP was obtained from Clontech.
 
Results
 
EGFP-tagged mCD14 Is Expressed on the Surfaces of U373
Cells.
 
To generate a fluorescently tagged CD14 that was
attached to the membrane via a GPI anchor, we fused a se-
quence coding for CD14 to one coding for EGFP and
added the sequence for the 36 COOH-terminal residues of
DAF. The chimeric protein resulting from the gene fusion
pCD14–EGFP–GPI, shown in Fig. 1, contains the NH
 
2
 
-
terminal signal peptide of CD14 and the COOH-terminal
signal peptide of DAF. Thus, when it was expressed and
processed, it would translocate normally into the endoplas-
mic reticulum and have a GPI anchor attached. For a con-
trol, we also engineered a chimeric EGFP with a GPI an-
chor that contained the NH
 
2
 
-terminal signal peptide (SP)
of CD14 and the COOH-terminal signal peptide of DAF.
This second chimera was used to compare the distribution
of EGFP-tagged CD14 (mCD14–EGFP) with a generic
GPI-anchored protein (mEGFP).
The two gene fusion products were transfected into the
U373 astrocytoma cell line, which does not express
mCD14. Stable transfectants for mCD14–EGFP and
mEGFP were designated U373–CD14–EGFP and U373–
EGFP, respectively. One clone of U373–CD14–EGFP was
used for the results presented, but a second clone gave
identical results.
Expression of mCD14–EGFP as an intact polypeptide in
U373–CD14–EGFP was tested in Western blots of cell ly- 
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sates run in parallel with rsCD14 and EGFP. Antibodies
against either CD14 or EGFP recognized the appropriate
control protein and the same single band at 80 kD in
U373–CD14–EGFP (Fig. 2). The band corresponded to a
protein of the expected mass for mCD14–EGFP and was
not present in cell lysates of untransfected U373. Thus,
mCD14–EGFP was expressed in U373 cells as an intact
polypeptide, and we can be confident that by observing
EGFP fluorescence we are also observing the location of
mCD14.
We further confirmed by confocal microscopy that both
mCD14–EGFP and mEGFP were expressed on the sur-
faces of U373 cells. Optical sections of live U373–CD14–
EGFP revealed fluorescence associated with the plasma
membrane that was relatively uniform in distribution (Fig.
3). Fluorescence was also observed on fine, filamentous
projections from the cell surface. Intracellular mCD14–
EGFP was observed in a juxtanuclear reticulum, a structure
characteristic of the Golgi apparatus. A similar labeling pat-
tern was observed with U373–EGFP (data not shown),
suggesting that this is a normal distribution of GPI-anchored
proteins in U373 cells.
To confirm that the mCD14–EGFP was attached to the
plasma membrane via a GPI anchor, we digested U373–
CD14–EGFP cells with PI-PLC, which cleaves GPI-anchored
proteins from their GPI anchors, before observing them by
 
confocal microscopy. After 1-h treatment at 4
 
8
 
C with PI-
PLC, cell surface fluorescence on U373–CD14–EGFP was
barely detectable (not shown), suggesting that most of the
cell surface associated mCD14–EGFP was removed.
 
EGFP-tagged mCD14 Enhances Responses of U373 Cells to
LPS.
 
U373 astrocytoma cells do not respond to LPS
Figure 1. Structure of the mCD14–EGFP and mEGFP chimeras. (A) mCD14–EGFP. The gene fusion carried by pCD14–EGFP–GPI encoded a pro-
tein comprising the NH2-terminal signal peptide and the first 348 amino acids of CD14, a hexapeptide spacer DPPVAT, EGFP minus the last COOH-
terminal amino acid (K), and a 36 COOH-terminal amino acid sequence from DAF signaling for attachment of a GPI anchor. (B) mEGFP. The gene fu-
sion carried by pSP–EGFP–GPI encoded a protein comprising the NH2-terminal SP of CD14, a hexapeptide spacer DPPVAT, EGFP minus the last
COOH-terminal amino acid (K), and a 36 COOH-terminal amino sequence from DAF for a GPI anchor.
Figure 2. mCD14–EGFP is expressed as a single polypeptide in U373
cells. Lysates from U373–CD14–EGFP and U373 cells (10 ml from each)
were run on SDS-PAGE along with 50 ng each of recombinant purified
EGFP and sCD14 in the indicated lanes. Western blots were probed with
either anti-CD14 or anti-EGFP pAb. 
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alone, but when LPS is added in the presence of sCD14,
they produce IL-6 (26). Transfection of U373 cells with
mCD14 allows responses to LPS in the absence of sCD14.
More importantly, it greatly increases the sensitivity of
these cells to LPS–sCD14 complexes and allows more
rapid responses to LPS–sCD14.
 
2
 
 This is consistent with ob-
servations that mCD14 on neutrophils and monocytes is
necessary for responses to LPS in the absence of sCD14 and
greatly increases the sensitivity of their responses to LPS–
sCD14 complexes (2, 9).
To show that the mCD14–EGFP chimera was func-
tional, we measured secretion of IL-6 by U373–CD14–
EGFP and U373–EGFP cells in response to either LPS or
LPS–sCD14 complexes. The U373–EGFP cells did not re-
spond to LPS alone up to 100 ng/ml (Fig. 4 A). In contrast,
 
2
 
Le Grand, C.B., N. Lamping, T. Sugiyama, S.D. Wright, and R.
Thieringer, manuscript submitted for publication.
Figure 3. mCD14–EGFP is expressed on the surfaces of U373 cells. Confocal microscopy was used to collect serial optical sections of a U373–CD14–
EGFP cell at 1-mm intervals, beginning at the top of the cell (A–H). A projection of all the sections is shown (P). mCD14–EGFP was localized to the cell
surface and Golgi apparatus, consistent with its being expressed and transported to the plasma membrane. 
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expression of mCD14–EGFP in U373 cells led to IL-6
production in response to concentrations of LPS of 1 ng/ml
or higher. Similarly, U373–CD14–EGFP cells responded
to concentrations of LPS–sCD14 
 
z
 
100-fold lower than
those required to elicit the same response in U373–EGFP
cells (Fig. 4 A). The enhancement of sensitivity by
mCD14–EGFP was quantitatively similar to that previously
observed with mCD14.
 
2
 
 Thus, the presence of EGFP does
not affect the function of mCD14–EGFP on cells.
To determine the time of exposure required to elicit a
response to LPS, U373–CD14–EGFP and U373–EGFP
cells were given a fixed concentration of LPS (40 ng/ml),
either alone or in sCD14 complexes, for increasing inter-
vals of time before washing and incubation to allow syn-
thesis of IL-6. U373–EGFP cells were essentially unrespon-
sive to LPS alone after up to 2 h of exposure (Fig. 4 B). As
previously seen with mCD14,
 
2
 
 the presence of mCD14–
EGFP dramatically enhanced the magnitude and speed of
cellular responses to LPS. In particular, after as little as 5
min of exposure to LPS, U373–CD14–EGFP cells re-
sponded with IL-6 production to both LPS–sCD14 com-
plexes (Fig. 4 B) and LPS aggregates (data not shown).
Taken together, these results suggest that mCD14–
EGFP was able to bind LPS and mediate cellular responses
to it. All of the properties exhibited by U373–CD14–
EGFP are the same as those of mCD14 expressed in
U373,
 
2
 
 indicating that mCD14 expressed as a chimera with
EGFP was still a functional entity. These results further
suggest that the distribution and trafficking pattern of
mCD14–EGFP in U373 would reflect that of a fully func-
tional protein.
 
LPS Binds to U373–CD14–EGFP and Colocalizes with
mCD14 on the Cell Surface.
 
The association of LPS with
mCD14–EGFP was confirmed by confocal microscopy.
BODIPY–LPS in the form of monomeric complexes with
sCD14 was incubated with U373–CD14–EGFP for 2–3
min at 37
 
8
 
C before washing and observation. Fluorescence
from BODIPY–LPS was seen associated with the plasma
membrane of U373–CD14–EGFP (Fig. 5 A, no Ab, red
panel), indicating that it was successfully transferred from
sCD14. There was colocalization of BODIPY–LPS with
mCD14–EGFP on the cell surface, as demonstrated by the
overlap in fluorescence signals (Fig. 5 A, no Ab, merge
panel). The same cell surface distribution of BODIPY–LPS
was observed with U373 transfectants expressing mCD14
without EGFP attached (Fig. 5 B, panel d). In contrast,
U373–EGFP cells incubated briefly with BODIPY–LPS–
sCD14 complexes did not have detectable BODIPY–LPS
fluorescence associated with their cell surfaces (Fig. 5 B,
panels a and b).
To confirm that the transfer of BODIPY–LPS from
sCD14 was mCD14 dependent, we pretreated U373–
CD14–EGFP cells with a blocking anti-CD14 mAb, 60b
(3). The antibody prevented binding of BODIPY–LPS,
and no colocalization with mCD14–EGFP was observed
(Fig. 5 A). Colocalization of BODIPY–LPS and mCD14–
EGFP was still observed when the cells were pretreated
with 26ic, a nonblocking anti-CD14 antibody (3) (Fig. 5
A). Thus, colocalization of BODIPY–LPS and mCD14 re-
quired binding of LPS to mCD14.
 
When Presented in a Monomeric Form, LPS Is Internalized
Separately from mCD14.
 
To determine whether LPS re-
Figure 4. Expression of mCD14–EGFP in U373 cells enhances the
sensitivity and speed of responses to LPS. (A) U373–CD14–EGFP re-
spond to lower concentrations of LPS than U373–EGFP. U373–CD14–
EGFP (h, j) and U373–EGFP (n, m) cells were incubated with the in-
dicated concentrations of LPS (h, n) or LPS–sCD14 complexes (j, m)
for 16 h at 378C, and IL-6 secretion was measured by ELISA. (B) U373–
CD14–EGFP respond to LPS more rapidly than U373–EGFP. U373–
CD14–EGFP (h, j) and U373–EGFP (n, m) cells were incubated with
LPS (h, n; 40 ng/ml) or LPS–sCD14 complexes (j, m; 40 ng/ml LPS,
1 mg/ml sCD14) for the indicated times at 378C. Cells were then washed
extensively and further incubated for 16 h at 378C. IL-6 secretion was
measured by ELISA. Results in A and B are expressed as the means of
triplicate wells 6 SEM and are from an experiment performed three
times with the same result. 
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mained bound to mCD14 after internalization, we ob-
served the trafficking of mCD14–EGFP and BODIPY–
LPS simultaneously in live cells. U373–CD14–EGFP cells
were incubated with BODIPY–LPS–sCD14 complexes for
2–3 min at 37
 
8
 
C, the complexes were removed by
washing, and the cells were incubated further at 37
 
8
 
C be-
fore observation. Particular attention was devoted to obser-
vations made 5–10 min after the incubation began. At the
earliest time points, BODIPY–LPS was clearly visible in
small intracellular vesicles (Fig. 6, 10 min, red panel). These
vesicles were visible at times as early as 5 min (data not
shown). However, the vesicles containing BODIPY–LPS
did not contain mCD14–EGFP, as evidenced by the lack
of overlap in fluorescent signals (Fig. 6, 10 min, merge
Figure 5. LPS and mCD14–EGFP colocalize on the cell surface. (A) U373–CD14–EGFP cells were incubated in HAP buffer with BODIPY–LPS–
sCD14 (40 ng/ml LPS) complexes for 3 min at 378C in the presence or absence of anti-CD14 and either the blocking mAb 60b or the nonblocking mAb
26ic. Confocal optical sections for mCD14–EGFP and BODIPY–LPS fluorescence are shown for representative cells in the left and center panels, respec-
tively, and the merged images are shown in the right panels. Yellow indicates regions where the signals overlap. In the absence of antibody or presence of
26ic, there was colocalization of mCD14–EGFP and BODIPY–LPS on the cell surface. In the presence of 60b, binding of LPS was inhibited, and there
was no colocalization of label. (B) U373–EGFP (a and b), U373 (c), and U373-CD14 (d) were incubated in HAP buffer with BODIPY–LPS–sCD14 (40
ng/ml LPS) complexes for 3 min at 378C. Confocal optical sections for mEGFP (a) and BODIPY–LPS (b–d) are shown for representative cells. Bars, 10 mm.516 Internalization of Monomeric LPS after Transfer out of Cell Surface CD14
Figure 6. LPS moves into the cell without mCD14–EGFP. U373–CD14–EGFP cells were incubated in HAP buffer with BODIPY–LPS–sCD14 (40
ng/ml LPS) complexes for 3 min at 378C, washed, and incubated further for 0, 10, 30, or 60 min at 378C. Confocal optical sections for mCD14–EGFP
and BODIPY–LPS fluorescence are shown for representative cells in the left and center panels, respectively, and the merged images are shown in the
right panels. Yellow indicates the regions where the signals overlap. Although there was colocalization of mCD14–EGFP and BODIPY–LPS on the cell
surface, internalized BODIPY–LPS did not colocalize with mCD14–EGFP. Bars, 10 mm.517 Vasselon et al.
panel). This indicates that in the brief time required for
LPS to reach a vesicular location, LPS had separated from
mCD14.
At later times, vesicles containing BODIPY–LPS accu-
mulated predominantly in the perinuclear area (Fig. 6, 30
and 60 min, red panels). Although by 60 min a punctate lo-
calization of mCD14–EGFP in the same vicinity was ob-
served (Fig. 6, 60 min, green panel), repeated observations
with LPS concentrations between 10 and 200 ng/ml
demonstrated that colocalization of BODIPY–LPS and
mCD14–EGFP in this area did not occur (not shown). LPS
concentration therefore had no effect on its localization.
Thus, not only did LPS leave mCD14 upon entering the
cells, but it also did not reassociate with mCD14 in any in-
tracellular compartment.
The kinetics of BODIPY–LPS internalization in U373–
CD14–EGFP were identical to those in U373 expressing
mCD14 without EGFP (data not shown). Furthermore,
the distribution of intracellular BODIPY–LPS in vesicles
and their subcellular localization was the same in both cell
types (data not shown). This indicates that the presence of
EGFP on mCD14 did not disturb the normal trafficking
pattern of LPS in U373 cells.
Intracellular CD14 Is Exocytosed in Response to LPS. Al-
though there was no apparent change in the distribution of
mCD14–EGFP in response to LPS in the colocalization
studies, the bright cell surface fluorescence prevented ob-
servation of any changes in the distribution of intracellular
mCD14–EGFP. To better observe the distribution of in-
tracellular mCD14–EGFP, we quenched the cell surface
fluorescence on U373–CD14–EGFP cells with trypan blue
(Fig. 7, A and B). In addition to the bright fluorescence
emanating from the Golgi apparatus area, numerous fluo-
rescent vesicles of z50–100-nm average diameter were
distributed throughout the cytoplasm. The vesicles were
particularly evident near the basal aspects of the cells (Fig. 7
B). A similar intracellular localization of mEGFP in the
Golgi complex and cytoplasmic vesicles was also observed
(data not shown). Thus, the vesicular compartment may
represent either a component of the secretory pathway en
route to the cell surface or a recycling compartment for
GPI-anchored proteins.
The effect of LPS on the intracellular distribution of
mCD14–EGFP was examined by adding LPS–sCD14
complexes to U373–CD14–EGFP cells and observing
mCD14–EGFP localization by confocal microscopy after
trypan blue quenching. The localization of mCD14–EGFP
in the Golgi complex was unaffected by LPS stimulation
(Fig. 7 C). However, after addition of LPS, we observed a
steady decrease in the number of mCD14–EGFP-contain-
ing vesicles from the earliest times observed (2–5 min),
with almost no mCD14–EGFP-containing vesicles remain-
ing after 45–60 min (Fig. 7 D), suggesting that the com-
partments containing mCD14–EGFP were exocytosed
Figure 7. CD14 is present in intracellular
vesicles that are exocytosed in response to
LPS. U373–CD14–EGFP cells were incu-
bated for 30 min at 378C in HAP buffer in
the absence (A and B) or presence (C and D)
of preformed LPS–sCD14 complexes (40 ng/
ml LPS). Trypan blue (200 mg/ml) was added
to quench mCD14–EGFP on the cell surface,
and the cells were examined by confocal micro-
scopy. Most of the intracellular mCD14–EGFP
was localized to a juxtanuclear reticulum (A
and C), presumably the Golgi apparatus. In
untreated cells, a pool of mCD14–EGFP was
also observed in vesicles located throughout
the cell but especially prevalent near the basal
aspect (B). Most of the vesicular pool of intra-
cellular mCD14–EGFP was no longer visible
after stimulation of the cells with preformed
LPS–sCD14 complexes (D). Bars, 10 mm.518 Internalization of Monomeric LPS after Transfer out of Cell Surface CD14
upon exposure of the cells to LPS. Although the resolution
of these experiments does not allow us to rule out the pos-
sibility that a small fraction of mCD14–EGFP was internal-
ized, the decline in the number of intracellular vesicles sug-
gests that exocytosis was the preferred route. A similar loss
of fluorescent vesicles was observed in U373–EGFP cells
exposed to LPS–sCD14 complexes for 45–60 min (data not
shown), indicating that the vesicle pool in question is not
defined by the presence of CD14 per se. These results sug-
gest that LPS either induces the release of a compartment
in U373 cells that contains GPI-anchored proteins or that it
prevents the reinternalization of a recycled pool of mem-
brane containing GPI-anchored proteins. Thus, rather than
being internalized with LPS from the cell surface, mCD14
apparently moved to the cell surface from an intracellular
store in response to LPS.
Exocytosis of the mCD14-containing vesicles was con-
firmed by quantitative measurements of the time course.
U373–CD14–EGFP cells were grown in 96-well tissue
culture plates, and both total and intracellular fluorescence
was measured before and at various times after exposure to
LPS–sCD14 complexes (see Materials and Methods). Stim-
ulation with LPS did not induce any change in total fluo-
rescence associated with the cells (data not shown) but did
induce a rapid decrease in intracellular mCD14–EGFP
(Fig. 8). A decrease of z20% in the intracellular fluores-
cence was observed after a 15-min incubation of U373–
CD14–EGFP cells with LPS–sCD14 complexes. A simi-
lar  decrease in intracellular fluorescence associated with
U373–EGFP cells was observed in response to LPS–sCD14
complexes (Fig. 8), indicating that the compartments re-
leased contained GPI-anchored proteins in addition to
mCD14–EGFP.
LPS Aggregates and mCD14 Colocalize on the Cell Surface
and Are Cointernalized. LPS aggregates are formed when
LPS micelles and LBP are incubated with little or no
sCD14. These LPS–LBP aggregates can bind to mCD14
on the surfaces of cells, and they are subsequently internal-
ized (27–29). However, binding of LPS–LBP aggregates by
mCD14 differs from binding of monomeric LPS presented
as a complex with sCD14. Aggregates bind at 48C, but mo-
nomeric LPS cannot be transferred from sCD14 to mCD14
at this temperature. In addition, although internalization of
monomeric LPS correlates with intracellular signaling (13,
14), internalization of LPS aggregates can be dissociated
from the generation of signals (27). These results suggest
that LPS aggregates may have a pathway for internalization
that is distinct from that of monomeric LPS.
To determine whether mCD14 traffics with LPS aggre-
gates during internalization, we incubated U373–CD14–
EGFP with BODIPY–LPS aggregates at concentrations be-
tween 40 and 100 ng/ml and followed both BODIPY–LPS
and mCD14–EGFP fluorescence by confocal microscopy.
After incubation for 5–10 min at 378C with BODIPY–LPS
aggregates, the cells were washed and incubated further at
378C. The aggregates bound to the cell surface and colocal-
ized with mCD14–EGFP (Fig. 9). At least 15 min at 378C
was required to detect BODIPY–LPS in intracellular vesi-
cles, suggesting that internalization of LPS aggregates was
somewhat slower than internalization of LPS monomers in
U373–CD14–EGFP. The mCD14–EGFP colocalized with
BODIPY–LPS in intracellular vesicles detected at the earli-
est times, although not all of the vesicles that contained
BODIPY–LPS also contained mCD14–EGFP. These re-
sults suggest that, in contrast with LPS monomers, LPS ag-
gregates can remain bound to mCD14 during internaliza-
tion. This supports the idea that there is more than one
pathway for internalization of LPS.
Discussion
Here we have used a chimeric construct of mCD14 with
EGFP transfected into the astrocytoma cell line U373 as a
probe for observing the distribution of mCD14 in living
cells. Labeling mCD14 directly with a fluorescent tag
avoided any perturbation of the distribution of mCD14, a
GPI-anchored protein, that might be caused by antibody
cross-linking (30). A variety of functional studies confirmed
that the mCD14–EGFP chimera was an intact and functional
protein that was attached to the cell surface via a GPI anchor.
Using this method, we observed that mCD14 was not
only expressed on the cell surface but was also present in-
Figure 8. Intracellular mCD14–EGFP is rapidly exocytosed. Adherent
U373–CD14–EGFP (h) and U373–EGFP (n) cells cultured in 96-well
plates were incubated with LPS–sCD14 complexes (40 ng/ml LPS) at
378C for the times indicated. At 0 min, no LPS was added. At the end of
the incubation, total fluorescence associated with the cells was measured
in a fluorescent plate reader. Trypan blue (200 mg/ml) was added to
quench extracellular fluorescence, and the remaining intracellular fluores-
cence was measured. Intracellular fluorescence was calculated as a per-
centage of total fluorescence in each well. Results are expressed as the
means of triplicate wells 6 SEM and are from an experiment performed
three times with the same result. *Direct comparison using Student’s t test
shows that these values are significantly different from the value of cells
incubated 0 min with LPS (P , 0.003).519 Vasselon et al.
tracellularly both in the perinuclear area and in small vesi-
cles near the basal aspect of the cells. These vesicles might
represent compartments in which mCD14, and perhaps
other GPI-anchored proteins, traffic from the Golgi appa-
ratus to the plasma membrane. They may also represent a
recycling compartment for GPI-linked proteins that are in-
ternalized from the plasma membrane and then returned to
it (31). Most of these vesicles were exocytosed when
U373–CD14–EGFP cells were exposed to LPS–sCD14
complexes, indicating that they are capable of fusion with
the plasma membrane.
The rapid exocytosis of the vesicles containing mCD14–
EGFP upon stimulation of U373–CD14–EGFP cells with
LPS was reminiscent of the exocytosis of secretory vesicles
containing mCD14 and other GPI-anchored proteins upon
stimulation of neutrophils with an agonist (25). Secretory
vesicles are thought to be an endocytic compartment, as
they also contain the serum proteins albumin and tetranec-
tin (32, 33). In response to formyl peptide, secretory vesi-
cles are brought rapidly to the neutrophil surface, augment-
ing the expression of GPI-anchored proteins on the plasma
membrane (25). Additional studies will be required to de-
termine whether any of the mCD14-containing vesicles in
U373–CD14–EGFP cells represent a recycling compart-
ment for GPI-anchored proteins similar to the secretory
vesicles of neutrophils.
Expression of mCD14–EGFP on the plasma membrane
enabled uptake of BODIPY–LPS (Figs. 5 and 6) and cellu-
lar responses to LPS (Fig. 4 A). CD14 binds LPS (34) and,
not surprisingly, added LPS was found to colocalize with
plasma membrane mCD14–EGFP (Figs. 5 and 6). After as-
sociation with the membrane, monomeric LPS is known to
be rapidly internalized (13, 14). Here we show that when
LPS was internalized, it moved into intracellular vesicles
that did not contain mCD14. Thus, we have demonstrated
in living cells that LPS, once it is bound by mCD14 on the
cell surface, is internalized without being accompanied by
its receptor. Together with our previous observations that
each mCD14 on the surfaces of human monocytes enables
the uptake of 15 LPS molecules in 30 min (3) and that this
uptake depends on an additional cell surface protein (3),
these observations support a model for LPS trafficking that
involves transfer of LPS from mCD14 to another cell sur-
face protein or to the lipid bilayer of the plasma membrane.
In addition to our studies with monomeric LPS, we have
also observed the trafficking of LPS aggregates. Aggregated
LPS may engage multiple copies of mCD14 on the cell
surface at the same time, and it may be more difficult for
mCD14 to transfer LPS from aggregates to the plasma
membrane. Using the mCD14–EGFP chimera, we ob-
served that mCD14 was internalized with aggregated LPS
in U373 cells. This behavior is opposite to that of LPS
monomers. It is, however, consistent with a variety of
other studies documenting different fates of monomeric
and aggregated LPS. After internalization, primarily through
noncoated structures (35), LPS aggregates move over the
course of several hours into a compartment that is likely to
be lysosomal in nature. There, acyloxyacyl hydrolase
deacylates and thus detoxifies LPS (18). Internalization of
aggregates can be disassociated from signaling (27, 29) and
thus appears more relevant to the detoxification and clear-
ance of LPS rather than signaling.
Several observations indicate a close correlation between
signaling and LPS transit to the Golgi complex. For exam-
Figure 9. LPS aggregates formed in serum are internalized with
mCD14–EGFP. U373–CD14–EGFP cells were incubated in HAP buffer
with aggregated BODIPY–LPS (100 ng/ml) for 10 min at 378C, washed,
and incubated for an additional 30 min at 378C before examination by
confocal microscopy. The images for mCD14–EGFP fluorescence and
BODIPY–LPS are shown in the top and center panels, respectively, and
the merged image is in the bottom panel. There was colocalization of
BODIPY–LPS and mCD14–EGFP on the cell surface and within many
intracellular compartments.520 Internalization of Monomeric LPS after Transfer out of Cell Surface CD14
ple, inactive structural analogues of LPS are not transported
to the Golgi complex (15), and cells from Lpsd mice, which
exhibit a defect in LPS signaling, fail to transport LPS to
the Golgi complex (14). Recent work has shown that Lpsd
mice are defective in Toll-like receptor (TLR)4, a member
of the IL-1 receptor family (36). In this regard, it is inter-
esting to note that the ligated IL-1 receptor type I (IL-1RI)
may require trafficking to an intracellular compartment to
generate signals (37). A thymocyte cell line has been identi-
fied that is defective in its responses to IL-1 and also does
not internalize IL-1RI. The defect can be overcome by
intracellular delivery of IL-1 (38) or by transfection with
IL-1R accessory protein (IL-1RAcP), which restores both
IL-1RI internalization (39) and IL-1 responses (39). Inter-
action of IL-1 with IL-1RI and IL-1RAcP triggers a cascade
of signaling events, including activation of the stress-acti-
vated, mitogen-activated protein (MAP) kinase pathways
and transcription factor NF-kB. Of interest in this regard is
that TLR4 shares homology in its cytoplasmic domain with
the IL-1R family (40), suggesting the possibility that it may
also share similar directions of intracellular trafficking.
Whether TLR4 colocalizes with LPS before or after trans-
port to the Golgi complex, however, will have to await
further studies.
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